Asia Pacific Contraceptive Drugs and Devices Market

Asia Pacific Contraceptive Drugs and Devices Market by Products (Devices [Diaphragms, Sponges, IUD, Condoms, Cervical Caps, Vaginal Rings, and Others], Drugs [Oral Contraceptives, Topical Contraceptives, and Contraceptive Injectable]), Gender (Male and Female), and Geography (India, Japan, China, South Korea, and Rest of Asia Pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

  • Report ID: HC-3807
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 213
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Asia Pacific contraceptive drugs and devices market size is anticipated to register a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the growing focus toward the requirement of family planning and avoiding unplanned pregnancy.

Asia Pacific Contraceptive Drugs and Devices Market Key Takeaways

Contraceptives are the name set to medicines and other devices that are utilized to prevent unwanted pregnancy. Contraception is characterized as the intentional avoidance of conception using different devices, sexual practices, synthetic compounds, drugs, or surgical methods. Hence, any device or act whose object is to keep a lady from becoming pregnant can be considered as a contraceptive. In any friendly setting viable contraception permits a couple to partake in an actual relationship unafraid of an undesirable pregnancy and guarantees sufficient opportunity to have kids when wanted. Some boundary strategies, similar to male and female condoms, additionally provide twin benefit of assurance from sexually transmitted diseases.

The outbreak of COVID19 pandemic has impacted the contraceptives drugs and devices market. The demand of drugs and devices is declined by around 50% to 60% in 2020. The disruption in supply chain, economic impact, consumer confidence, and other factors have negatively influenced the market growth.

Market Trends, Drivers, Restraints, and Opportunities

  • The requirement to avoid unwanted pregnancies, especially in teenage women, is expected to drive the market growth.
  • The increase in use of contraception in young women along with rise in higher educational attainment is anticipated to spur the growth of market.
  • Increase in awareness of modern contraception, and rise in use of oral pills are expected to boost the market in the coming years.
  • Health risks associated with the use of contraceptives and availability of alternate contraceptive methods can hamper the growth of the market.
  • Lack of social acceptance can create challenges for the market growth.
  • Increasing incidence of STDs and the rapid increase in population is one of the major drivers of the market.

Scope of the Report

The Asia Pacific contraceptive drugs and devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Contraceptive Drugs and Devices Market - Asia Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Devices [Diaphragms, Sponges, IUD, Condoms, Cervical Caps, Vaginal Rings, and Others], Drugs [Oral Contraceptives, Topical Contraceptives, and Contraceptive Injectable]), and Gender (Male and Female)

Geographical Scope

India, Japan, China, South Korea, and Rest of Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Pfizer Inc.; CooperSurgical, Inc.; Bayer AG; Merck & Co., Inc.; and Allergan PLC

Asia Pacific Contraceptive Drugs and Devices Market Segment Insights

Oral contraceptive segment to hold a major market share

In terms of products, the market is bifurcated into devices and drugs. The devices segment is further classified as diaphragms, sponges, IUD, condoms, cervical caps, vaginal rings, and others. The drugs segment is categorized as oral contraceptives, topical contraceptives, and contraceptive injectable. The oral contraceptives segment is projected to expand at a considerable CAGR during the forecast period as oral contraceptives pills is seen as easy method of contraception in the industry. They act by disallowing implantation inside the uterus whenever taken during 2-3 days of sexual contact. The effortlessness of their use makes them an optimal preventative on the lookout. These are effectively marketed across the locale by organizations, and in this manner, effortlessly consumed by a huge part of the population.

Female segment is anticipated to constitute a key market share

On the basis of gender, the market is segregated into male and female. The female segment is expected to constitute a key share of the market during the projected period, as it regulates menstrual cycle and makes periods less painful. It can be helpful for females in many ways such as banish hormonal acne, reduces risk of uterine cancer, and declines risk of ovarian cysts.

Asia Pacific Contraceptive Drugs and Devices Market By Gender

The market in India is estimated to expand at a robust pace

Based on geography, the market can be classified as India, Japan, China, South Korea, and Rest of Asia Pacific. The market in India is anticipated to grow at a rapid pace during the forecast period due to increasing awareness regarding family planning from government state bodies.

Segments

The Asia Pacific contraceptive drugs and devices market is segmented on the basis of:

Products
  • Devices
    • Diaphragms
    • Sponges
    • IUD
    • Condoms
    • Cervical Caps
    • Vaginal Rings
    • Others
  • Drugs
    • Oral Contraceptives
    • Topical Contraceptives
    • Contraceptive Injectable
Gender
  • Male
  • Female
Geography
  • India
  • Japan
  • China
  • South Korea
  • Rest of Asia Pacific
Key Players
  • Pfizer Inc.
  • CooperSurgical, Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Allergan PLC.

Competitive Landscape

The key players competing in the Asia Pacific contraceptive drugs and devices market are Pfizer Inc.; CooperSurgical, Inc.; Bayer AG; Merck & Co., Inc.; and Allergan PLC.

Asia Pacific Contraceptive Drugs and Devices Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Contraceptive Drugs and Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Contraceptive Drugs and Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Contraceptive Drugs and Devices Market - Supply Chain
  4.5. Global Contraceptive Drugs and Devices Market Forecast
     4.5.1. Contraceptive Drugs and Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Contraceptive Drugs and Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Contraceptive Drugs and Devices Market Absolute $ Opportunity
5. Global Contraceptive Drugs and Devices Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Contraceptive Drugs and Devices Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Contraceptive Drugs and Devices Demand Share Forecast, 2019-2026
6. North America Contraceptive Drugs and Devices Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Contraceptive Drugs and Devices Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Contraceptive Drugs and Devices Demand Share Forecast, 2019-2026
7. Latin America Contraceptive Drugs and Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Contraceptive Drugs and Devices Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Contraceptive Drugs and Devices Demand Share Forecast, 2019-2026
8. Europe Contraceptive Drugs and Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Contraceptive Drugs and Devices Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Contraceptive Drugs and Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Contraceptive Drugs and Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Contraceptive Drugs and Devices Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Contraceptive Drugs and Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Contraceptive Drugs and Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Contraceptive Drugs and Devices Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Contraceptive Drugs and Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Contraceptive Drugs and Devices Market: Market Share Analysis
  11.2. Contraceptive Drugs and Devices Distributors and Customers
  11.3. Contraceptive Drugs and Devices Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Pfizer Inc.
     11.4.2. CooperSurgical, Inc.
     11.4.3. Bayer AG
     11.4.4. Merck & Co., Inc.
     11.4.5. Allergan PLC.
The Asia Pacific contraceptive drugs and devices market is segmented on the basis of:

Products
  • Devices
    • Diaphragms
    • Sponges
    • IUD
    • Condoms
    • Cervical Caps
    • Vaginal Rings
    • Others
  • Drugs
    • Oral Contraceptives
    • Topical Contraceptives
    • Contraceptive Injectable
Gender
  • Male
  • Female
Geography
  • India
  • Japan
  • China
  • South Korea
  • Rest of Asia Pacific
Key Players
  • Pfizer Inc.
  • CooperSurgical, Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Allergan PLC.

The key players competing in the Asia Pacific contraceptive drugs and devices market are Pfizer Inc.; CooperSurgical, Inc.; Bayer AG; Merck & Co., Inc.; and Allergan PLC.

Asia Pacific Contraceptive Drugs and Devices Market By Key Players

Buy Report